Stay updated with breaking news from Downstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Several contract development and manufacturing organization (CDMO) supported biopharma projects have been flagged in the past month. We take a closer look.
From industrializing mRNA manufacture to the implications of a potential IP waiver on COVID-19 vaccine production, hear from the experts in our free webinar this week.
Waters has announced a five-year investment to develop new analytical technology for bioprocessing and biomanufacturing with the University of Delaware.
Novartis has signed a new initial agreement with BioNTech for COVID-19 vaccine manufacturing: with its sterile manufacturing facilities in Ljubljana, Slovenia, to fill at least 24 million doses in 2022.
The European Medicines Agency’s human medicines committee (CHMP) has approved two new additional manufacturing sites for Comirnaty in Italy.